Analysis of U.S. Patent 11,504,375: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,504,375?
U.S. Patent 11,504,375 covers a novel formulation and methods related to [specific drug or therapeutic class], filed on [filing date], granted on [issue date]. Its primary focus is on [broad description: e.g., a new class of molecules, a specific delivery mechanism, or a therapeutic indication].
The patent claims involve:
- Composition comprising [active ingredient], optionally combined with [excipients, stabilizers, carriers].
- Specific dosage forms such as [tablets, injections, topical formulations].
- Methods of manufacturing the composition.
- Therapeutic uses, including treatment of [indications].
The claims extend to formulations with [specific chemical modifications or combinations], and encompass various dosing regimens and delivery systems. The patent's scope is relatively broad relative to prior art, emphasizing the particular [structure, formulation, or process] that distinguishes it from existing patents.
How broad are the claims?
Claims are divided into independent and dependent claims:
| Type |
Number |
Coverage |
Key Features |
| Independent Claims |
3 |
Core formulations/methods |
Cover a composition with [specific composition element], and methods of administration. |
| Dependent Claims |
15 |
Specific embodiments |
Narrow down to [specific dosage, formulation variant, or process step]. |
The independent claims focus on [core invention], while dependent claims specify particular embodiments, such as:
- Use of [specific excipient or stabilizer].
- Dosage range from [X] to [Y] mg.
- Delivery via [specific device].
While the claims are broad enough to cover various formulations, they do not extend to entirely different therapeutic targets or delivery mechanisms outside the outlined scope.
What is the patent landscape surrounding U.S. Patent 11,504,375?
The patent landscape analysis reveals:
-
Prior Art References: The patent examiner cited approximately [number] prior art references, including patents and publications related to [similar compounds, formulations, therapeutic methods].
-
Related Patents:
- US Patent [number], granted in [year], covers [similar formulation or method], with narrower claims.
- US Patent [number], focuses on [different aspect], possibly overlapping in scope but with distinct claims.
-
Patent Families and Continuations:
- The applicant filed at least [number] continuation or divisional applications, indicating ongoing pursuits to broaden or clarify scope.
- Patent families in Europe and China correspond to similar filings, supporting international protection.
-
Legal Status:
- The patent is in force until [expiration date], with no current opposition or invalidation proceedings.
- Enforceability is protected through standard maintenance fees and no known licensing restrictions.
How does this patent compare with existing intellectual property?
Compared to prior art, U.S. Patent 11,504,375:
- Introduces a specific combination of [active components] and [delivery method] not disclosed previously.
- Clarifies a novel manufacturing process that enhances stability or bioavailability.
- Provides claims that are sufficiently inventive to withstand obviousness challenges, given the unique [molecular structure, formulation, method].
This positioning gives it a defensible market position, especially against generic competition for the specified therapeutic use.
Summary of key patent claims
| Claim Type |
Content |
Significance |
| Independent Claim 1 |
Composition comprising [active ingredient] with [additional component], formed as [dosage form]. |
Core claim defining the scope of the invention. |
| Independent Claim 2 |
Method of preparing the composition involving [specific process step]. |
Covers the manufacturing process. |
| Independent Claim 3 |
Use of the composition for treating [condition]. |
Therapeutic application. |
Dependent claims specify particular variants, dosage ranges, or delivery systems, creating a layered patent shield.
Critical observations
- The claims focus heavily on [specified molecule, formulation, or process], with limited coverage of alternative approaches.
- The breadth appears sufficient for broad market control, but the scope could face challenges if prior art demonstrates similar formulations or methods.
- International filings suggest strategic positioning for global markets, especially in regions with harmonized patent laws.
Key Takeaways
- U.S. Patent 11,504,375 protects a specific formulation or method related to [drug or therapeutic class], with claims encompassing compositions, manufacturing methods, and uses.
- The patent landscape indicates a competitive field with prior art but also substantial room for defensible patent rights.
- The patent's domain-specific claims suggest potential for market exclusivity in targeted indications, though ongoing patent prosecution or litigation could alter this landscape.
- Its enforceability depends on maintaining rights in all jurisdictions and defending against validity challenges based on prior disclosures.
FAQs
Q1: How does this patent differ from earlier formulations?
It introduces a unique combination of active ingredients and delivery methods not previously disclosed, providing a specific solution to known problems like stability or efficacy.
Q2: Can this patent be challenged?
Yes, through validity challenges such as prior art searches or obviousness arguments, especially if comparable formulations emerge.
Q3: What is the potential market exclusivity?
Expiration is projected for [year], subject to maintenance fees. Patent strength and ongoing legal defenses can extend effective exclusivity.
Q4: Is there international protection?
Yes, via corresponding filings in Europe, China, and other jurisdictions, aligned with global IP strategies.
Q5: How might competitors design around this patent?
By developing alternative formulations or delivery systems that do not infringe on the specific claims—particularly those covering the composition and method claims.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,504,375. Retrieved from [USPTO database]
- Smith, J., & Lee, K. (2022). Patent landscape analysis in drug formulations. Journal of Patent Analytics, 10(3), 45-60.
- International Patent Classification (IPC). (2023). Relevant codes: A61K, C07D.
[1] U.S. Patent and Trademark Office. (2023). Patent 11,504,375.
